parthenolide has been researched along with Atherogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, D; Liu, LP; Liu, N; Zhang, HN | 1 |
| Blanco, J; Egido, J; Gómez-Guerrero, C; Hernández-Vargas, P; López-Franco, O; Ortega, L; Ortiz-Muñoz, G; Sanjuán, G; Suzuki, Y | 1 |
2 other study(ies) available for parthenolide and Atherogenesis
| Article | Year |
|---|---|
Exploring and validating the metastasis mechanism of pathenolide interfering with cutaneous melanoma through ER stress-dependent apoptosis based on the network pharmacology.
Topics: Apoptosis; Atherosclerosis; Drugs, Chinese Herbal; Melanoma; Melanoma, Cutaneous Malignant; Molecular Docking Simulation; Network Pharmacology; Skin Neoplasms | 2023 |
Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis.
Topics: Animals; Apoptosis; Atherosclerosis; Cell Division; Cells, Cultured; Dietary Fats; Humans; Inflammation; Mice; NF-kappa B; Sesquiterpenes | 2006 |